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ABSTRACT
The control of coccidiosis in chickens is undertaken mainly by administration of anticoccidial drugs. 
Sulfachloropyrazine-sodium is still used as an effective coccidiocidal compound to treat poultry with clinical 
signs of coccidiosis. However, its disposition after three days treatment in Eimeria tenella infected chickens 
has not been well studied. Pharmacokinetics of sulfachlorpyrazine-sodium was investigated in healthy chickens 
and chickens experimentally infected with E. tenella. Serum and tissue concentrations were determined by 
HPLC-PDA analysis. The values of absorption half-life (17.24 ± 3.50 h) and time for achievement of maximal 
serum concentrations Tmax (23.41 ± 3.78 h) of the sulfonamide were signifi cantly higher in infected chickens. An 
accumulation index of 1.22 ± 0.13 was estimated and signifi cantly higher serum concentrations were observed 
in E. tenella challenged animals. Signifi cantly higher sulfachloropyrazine-sodium levels were found in the 
duodenum, caeca and the liver, which suggests that a longer withdrawn time could be expected in infected 
chickens after three days administration of the anticoccidial agent. The observed changes in sulfachloropyrazine 
disposition could be attributed to the alteration of the integrity of the intestines and decreased motility of the 
gastro-intestinal tract during the clinical coccidiosis. 
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Introduction
Coccidiosis is one of the major problems in poultry husbandry with signifi cant 
economic impact on broiler chicken production (HAUG et al., 2008). The potential for 
clinical and subclinical coccidiosis is always a concern, since coccidial oocysts are present 
in broiler farms. Despite prophylactic feeding programs, which include administration 
of coccidiostatic drugs, it is occasionally necessary to apply cocidiocidal compounds to 
*Corresponding author:
Aneliya M. Haritova, Department of Pharmacology, Physiology of Animals and Physiological Chemistry, Faculty of Veterinary 
Medicine, Trakia University, 6000 Stara Zagora, Bulgaria, Phone: +359 42 699 696; E-mail: haritova@uni-sz.bg
212 Vet. arhiv 83 (2), 211-222, 2013
A. M. Haritova et al.: Sulfachloropyrazine disposition in chickens
treat the coccidiosis (GUSSEM, 2007). Treatment with drinking water is more valuable in 
clinical cases of protozoal disease because water consumption is continued by the poultry. 
However, the range of available compounds is limited and includes mainly toltrazuril and 
sulfonamides (LACZAY et al., 1995). 
Sulfonamides are relatively old synthetic antibacterial compounds but still effective 
in the treatment of caecal coccidiosis in poultry (LACZAY et al., 1995; CAMPBELL, 2008). 
They interfere with the synthesis of folic acid, which is required for deoxyribonucleic 
acid synthesis (GREIF et al., 2001). The equal or greater effi cacy of sulfachlorpyrazine has 
been observed in E. tenella infected chickens in comparison to toltrazuril during the early 
stage of life cycle, or in the late stages of the parasite’s development, respectively. Due to 
antibacterial activity, the sulfonamide drug prevents secondary bacterial infections which 
often occur after coccidiosis (YEQUANI and KORVER, 2008). Although sulfachloropyrazine 
was often used as a coccidiocidal drug in clinical cases, its disposition in infected poultry is 
not well described in the literature. The published data concern mainly pharmacokinetics 
after single intravenous and oral administration of the drug (LASHEV, 1998; KOINARSKI 
and LASHEV, 2006). Recently, LEBKOWSKA-WIERUSZEWSKA and KOWALSKI (2010) 
published residue depletion studies in healthy turkeys treated with sulfachloropyrazine. 
These investigations showed that sulfachloropyrazine has a long half-life and relatively 
high bioavailability. The drug was found at measurable concentrations in the edible 
tissues of turkeys eighteen days after the cessation of treatment. Delayed absorption rates 
have been observed in Eimeria infected chickens and turkeys (LASHEV, 1998). However, 
data are lacking about the pharmacokinetics of sulfachloropyrazine administered for three 
consecutive days to E. tenella infected chickens. Although a longer withdrawal time can 
be assumed in diseased animals on the basis of a single administration of the drug, there 
are no data about sulfachloropyrazine disposition after continuous treatment of infected 
chickens. 
Therefore, the current study was designed to evaluate the pharmacokinetics of 
sulfachloropyrazine in Eimeria tenella infected chickens. The analysis of the serum and 
the tissue concentrations in the liver, the intestinal walls of the duodenum and caeca, 
was performed by the HPLC method. Additionally, the effi cacy of the treatment was 
determined by registration of the oocyst index and lesion score.
Materials and methods
Drug. Sulfachloropyrazine-sodium monohydratum (Sudachim, Ltd., Sofi a, Part. 
No 20070415) was used for oral (p.o.) treatment. The drug was administered as a water 
solution according to the manufacturers’ instructions at a concentration of 0.03%. The 
medicated water was prepared ex tempore and was supplied ad libitum. The treatment 
aimed for a dose of sulfachloropyrazine 70 mg/kg b.m./day. Water consumption was 
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registered, as well as the body weight of the chickens, and the received daily dose was 
calculated to be 70 mg/kgb.m./day. 
Animals. Broiler chickens from both sexes (Plymouth Rock × Cornish, n 127) 
were included in the experiment. They were obtained from a commercial poultry farm 
immediately after hatching. The chickens were housed under identical conditions, 
according to the requirements of the species (Bulgarian Regulation No. 15/03 Feb 2006 
for minimum requirements for the protection and welfare of experimental animals). They 
had free access to standard commercial feed (without antibiotics and coccidiostats) and 
water. The animals were reared in cages, on a grilled fl oor and under conditions excluding 
an additional invasion of Eimeria spp. The birds were regularly examined during the 
experiment. They were free of cocidiosis and infectious disease during the acclimatization 
period and before the experimental infection. The experimental animals were divided into 
three groups at the age of 14 days. The chickens were of body weight between 214 and 
305 g at that age.
Study design and treatment. The fi rst group of 50 chickens was housed separately 
in order to prevent any Eimeria infection. They served as healthy controls. Ten chickens 
remained untreated. The remaining 40 animals received sulfachloropyrazine-sodium via 
drinking water for 3 consecutive days. The treatment started at the age of 21 days, thereby 
healthy and infected animals were treated at an identical age. The chickens were of body 
weight between 367 and 529 g. Water consumption was registered and the recalculated 
dose received did not differ from the target dose of 70 mg/kg b.m./day. The blood samples 
(0.8 mL) were taken from the v. brachialis. They were collected in tubes without an 
anticoagulant prior to treatment and at 1, 2, 4, 6, 24, 50, 54, 74, 76, 78 and 80 hours after 
the start of the treatment. Six samples were taken at each time interval during the fi rst 24 
hours from different animals and fi ve samples per each time interval until the end of the 
experiment. Serum was collected after centrifugation at 1800g for 15 min and stored at 
-30 °C prior to analyses. The liver, duodenum, caeca and caecal content were collected 
50, 54, 74, 76, 78 and 80 h after the start of the treatment. Five animals were euthanized 
by cervical dislocation at each time interval to obtain the tissue samples. Serum and tissue 
samples were also taken from healthy untreated animals for control blank samples and for 
the preparation of standard curves, for HPLC analysis of drug concentrations. 
The second (n = 50) and the third (n = 27) groups consisted of infected chickens. They 
were infected with E. tenella at the age of 15 days. The chickens from the second group 
were treated with sulfachloropyrazine-sodium via drinking water for 3 consecutive days. 
The treatment started at the age of 21 days, 6 days after the infection and after the fi rst 
clinical signs of coccidiosis. The animals ingested 67 mg/kg sulfachlorpyrazine-sodium, 
almost equal to the target dose of 70 mg/kg. Serum and tissue samples were collected in 
the same manner and at the same time intervals as described for healthy treated animals. 
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In order to determine parasitological parameters, samples from the caecum were taken 
on the second (n = 6), third (n = 8) and forth (n = 20) days after the start of the treatment. 
Tissue samples from these animals were also used for determination of the concentrations 
of sulfachloropyrazine in the duodenum, caecum, caecal content and liver. 
The animals from the third group remain untreated until the end of the experiment. 
Tissue samples for parasitological observation from these animals were taken seven days 
after infection (n = 6) as well as on the eighth (n = 8) and ninth (n = 8) days after the 
challenge with E. tenella. The dead animals (n = 21) from both infected groups (second 
and third groups) were subjected to pathological examination.
Experimental infection. Eimeria tenella strain was isolated from naturally invaded 
chickens and enriched via transmission through susceptible birds. A 0.4 mL volume of E. 
tenella culture containing 8 × 104 sporulated oocysts was instilled into the crop of each 
chicken. The animals were infected at the age of 15 days. Clinical signs of infection were 
seen in most animals within 6 days after inoculation. Mortality rate, lesion score and 
oocyst index were registered. Lesion scoring is the numerical ranking of gross lesions 
caused by coccidia. A score of 0 was set when lesions were not determined; a score of 1 
if mild lesions were observed; a score of 2 for moderate lesions; 3 for severe lesions and 
4 when extremely severe lesions were recorded (JOHNSON and REID, 1970). 
Sulfachlorpyrazine concentrations in serum and tissues. Analytical work 
was performed in the Central Scientifi c Laboratory, Trakia University. The serum 
concentrations of sulfachloropyrazine were determined using the HPLC method with minor 
modifi cations (KOWALSKI et al., 2009). KOWALSKI et al. (2009) showed that this analytical 
method has high specifi city and sensitivity and adequate precision and accuracy. Briefl y, 
2 mL acetonitrile was added to serum samples (200 L). The samples were centrifuged 
for 5 min at 339 ×g. The organic phase was collected and was evaporated in a vacuum 
evaporator at 40oC. The residue was dissolved in 200 L of demineralized Milli-Q-water. 
Extraction of the antibacterial compound from tissues was performed according to the 
method cited. A 20 L aliquot was injected into the HPLC system comprising a Hypersil 
Spherisorb ODS-2 (C18)-150 × 4.6 mm 5 M column, a Surveyor LC Pump Plus and 
Surveyor PDA detector and Surveyor Autosampler Plus (Thermo Fisher Scientifi c Inc., 
USA). The samples and standard solutions were monitored at a wavelength of 270 nm. 
The mobile phase consisted of acetonitrile in aqueous solution (25:75, v/v) of potassium 
dihydrogenophosphate (0.02 M) in water. The pH of the phosphate buffer was adjusted 
to 2.7 with phosphoric acid (85%). The fl ow rate was 1.4 mL/min. Peak area integrations 
were measured by the ChromQuest Chromatography Data System (Thermo Fisher 
Scientifi c Inc., USA). Standard dilutions of sulfachloropyrazine-sodium were prepared in 
the serum and tissues obtained from untreated chickens at concentrations of 100, 50, 10, 
5, 1, 0.5 and 0.2 g/mL and subjected to HPLC analysis. 
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Sulfadiazine sodium was used as an internal standard. The internal standard was 
added to each sample, including standard solutions, at a concentration of 1 mg/mL. 
The peak area ratio of sulfachloropyrazine-sodium to the internal standard was used for 
construction of the standard curves. The standard curve was linear over the range of 
the tested concentrations (r = 0.999). The intra-assay and the inter-assay coeffi cients of 
variation (CV) were 2.32 and 11.21, respectively. The limit of detection was 0.2 g/mL 
and the limit of quantifi cation was 0.5 g/mL. Experiments with spiked tissue samples 
demonstrated that the overall recovery rate in the liver exceeded >77% and in the other 
tissue specimens it exceeded >65%. 
Pharmacokinetic analysis. Pharmacokinetic analysis of the data was performed 
using a non-compartmental model, steady state mode (WinNonlin 5.0.1., Pharsight 
Corporation, 800 West El Camino Real, Mountain View, CA, USA). The area under 
the serum-concentration-time curve (AUC) was calculated by the method of trapezoids, 
between the times 0 and 80 h. Maximum serum concentration (Cmax) and the time to 
reach Cmax (Tmax) were taken directly from the observed data, average (Cavg) and minimum 
(Cmin) serum concentrations were calculated. Mean residence time (MRT) was also 
calculated. Additionally, data were analyzed by the one-compartmental model (Model 
3 from WinNonlin library). Absorption (k01) and elimination () rate constants, and 
respective half-lives were calculated on the basis of simulated serum concentrations for 
three consecutive days. Cmax and Tmax were also predicted with the performed simulations. 
Pharmacokinetic parameters were calculated by the naive pooling approach. The 
individual concentrations measured at each time interval were grouped and then time-
concentration curves were analyzed for six animals. 
Statistical analyses. The pharmacokinetic parameters of sulfachlorpyrazine were 
presented as mean ± SD. They were computed with the Statistica 6.1 computer program 
(Statistica for Windows, StatSoft, Inc., USA, 1984-2002). Mann-Whitney test was used 
for statistical evaluation of differences between healthy and infected animals. Level of 
signifi cance P<0.05 was considered as signifi cant.
Results
Clear clinical signs of caecal cocidiosis appeared within six days after the experimental 
infection with E. tenella. Gross pathological changes such as erosions of the mucosa, 
blood in the intestinal lumen as well as enlargement of the intestinal size were observed 
in the caecum. The lesion score and the oocyst index in the treated animals were lower 
and reached zero at the end of the treatment. In contrast, these parameters in untreated 
animals were one and twenty at the end of the experiment, respectively. Body weight 
of the healthy and uninfected chickens before the challenge with E. tenella was 258.63 
± 36.04 g. At the end of the experiment, the body weight of the infected animals was 
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signifi cantly lower in comparison to healthy and to infected and treated animals. The 
last group of animals did not reach the body weight of healthy chickens (Table 1). The 
mortality of untreated and treated groups was 44% and 18%, respectively.
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(22 days old)
Eight days after 
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(23 days old)















Healthy (n = 50) 592.90 ± 78.94a 0 0 0 0 0 0






treated (n = 50) 504.15 ± 93.36







a, b, c - statistically signifi cant differences at P<0.05 between healthy, infected and infected and treated animals; 
LS - lesion score; OI - oocyst index.
Fig. 1. Predicted (lines) and observed (dots) serum concentrations of sulfachlorpyrazine-sodium 
after administration for three consecutive days via drinking water at a dose rate of (70 mg/kg) in 
healthy (n = 40) and E. tenella infected (n =  50) chickens. Thick line and triangles show data for 
infected poultry and thin line and squares - data for healthy animals. 
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Serum concentrations of sulfachlorpyrazine are shown on Fig. 1. Pharmacokinetic 
parameters of healthy and infected animals are presented in Tables 2 and 3. After 
simulation of the serum concentrations with one-compartmental method of analysis, 
signifi cantly lower value of absorption rate constant and higher values of respective half-
live as well as predicted Tmax were observed in infected animals. Predicted Cmax values for 
fi rst hours after treatment based on simulated serum concentrations were insignifi cantly 
lower in infected animals. In contrast, the observed Cmax, and the calculated Cavg and 
Cmin values during the three days treatment period were signifi cantly higher in infected 
animals. Similar changes were found in the values of the concentrations measured in 
the liver, intestinal walls and caecal content (Fig. 2). The other parameters were not 
signifi cantly changed.
Table 2. Pharmacokinetic parameters of sulfachlorpyrazine at a dosage of 70 mg/kg b.m. after oral 
(p.o.) administration in healthy (n 40) and infected with E. tenella (n = 50) chickens, mean ± SD 
Pharmacokinetic 
parameters Units Sulfachlorpyrazine, (p.o., 70 mg/kg b.m.) 
Healthy animals Infected animals
One-compartmental analysis 
k01 h
-1 0.68 ± 0.51 0.04 ± 0.01*
t1/201 h 2.12 ± 2.45 17.24 ± 3.50* h-1 0.06 ± 0.03 0.04 ± 0.01
t1/2 h 14.71 ± 5.22 17.31 ± 3.45
Cmax (predicted) g.mL-1 117.36 ± 17.32 90.91 ± 9.09
Tmax (predicted) h 5.28 ± 2.51 23.41 ± 3.78*
Non-compartmental analysis
Cmax (obserevd) g.mL-1 164.18 ± 38.46 210.38 ± 16.65*
Tmax (obserevd) h 51.60 ± 2.19 52.0 ± 2.19
Cmin g.mL-1 113.36 ± 24.74 172.99 ± 13.47*
Cavg g.mL-1 120.04 ± 34.05 176.17 ± 18.91*
MRT h 15.90 ± 2.89 28.12 ± 8.64
AUC0-80h g.h.mL-1 2972.24 ± 1298.01 4855.95 ± 1948.27
Accumulation index 1.09 ± 0.13 1.22 ± 0.13
k01 - absorption rate constant; t1/201 - absorption half-live;  - elimination rate constant; t1/2 - terminal elimination 
half-life; Cmax - maximum serum levels; tmax - time of Cmax; Cavg - average serum concentration; Cmin - minimum 
serum concentration; AUC0-∞ - area under the serum concentration-time curves from 0 h to ∞; AUC0-80h - area 
under the serum concentration-time curves from 0 h to 24 h; MRT - mean residence time; * - statistically 
signifi cant differences at P<0.05
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Table 3. Concentrations (mean ± SD) of sulfachlorpyrazine in the intestinal tissues from 
duodenum and caeca, the content of caeca and the liver.
Pharmacokinetic 
parameters Units






Cmax g.g-1 92.75 ± 8.73 176.92 ± 33.31*
Cmin g.g-1 56.06 ± 24.03 119.23 ± 26.03*
Cavg g.g-1 68.82 ± 13.81 123.07 ± 26.54*
Accumulation index 1.48 ± 0.30 4.95 ± 3.10*
Withdrawal time h 243.17 683.82
Content of caecum
Cmax g.g-1 124.44 ± 81.23 277.92 ± 198.36
Cmin g.g-1 98.69 ± 83.98 171.92 ± 161.20
Cavg g.g-1 100.10 ± 49.60 210.94 ± 0.00
Accumulation index 1.13 ± 0.24 1.94
Duodenum 
Cmax g.g-1 68.85 ± 17.02 125.71 ± 16.35*
Cmin g.g-1 41.29 ± 15.01 90.35 ± 7.69*
Cavg g.g-1 48.90 ± 15.80 103.56 ± 12.08*
Accumulation index 1.54 ± 0.39 3.11 ± 1.36*
Withdrawal time h 229.70 481.72
Liver
Cmax g.g-1 73.03 ± 7.75 159.95 ± 50.60*
Cmin g.g-1 50.31 ± 18.20 105.07 ± 25.49*
Cavg g.g-1 57.68 ± 17.59 107.72 ± 12.56*
Accumulation index 1.57 ± 0.46 3.65 ± 2.52
Withdrawal time h 250.90 424.18
Cmax - maximum serum levels; Cavg - average serum concentration; Cmin - minimum serum concentration; .* - 
statistically signifi cant differences at P<0.05
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Fig. 2. Observed concentrations of sulfachlorpyrazine-sodium in the liver (A), caeca (B), content 
in the caeca (C) and duodenum (D) after administration of the drug for three consecutive days 
via drinking water at a dose rate of (70 mg/kg) in healthy (n = 40) and E. tenella infected (n = 
50) chickens. ◊ - data for infected poultry; ♦ - data for healthy animals. * - statistically signifi cant 
difference at P<0.05.
Discussion
Antibacterial and cocidiocidal effect of sulfachlorpyrazine have been well described 
in the literature. The effi cacy of the sulfonamide drug against the oocysts at different 
stages of development was compared with other anticocidial drugs in many investigations 
(LACZAY et al., 1995; SIDDIKI et al., 2008; ILIE et al., 2009). Although this drug is used 
many years, its pharmacokinetics, including the disposition in the target tissues of 
Eimeria spp. infected chickens is not well described. Most of the publications contain 
data about the sulfachlorpyrazine disposition after single oral administration (HARITOVA 
and LASHEV, 2002; KOINARSKI and LASHEV, 2006). Therefore, in our study we described 
sulfachlorpyrazine pharmacokinetics in chickens experimentally infected with E. tenella 
and treated with the drug for three consecutive days via the drinking water. 
The experimental infection with E. tenella in our study resulted in signifi cant injuries 
in the mucosa of the caeca up to day six post infection. The observed changes, expressed 
by the determination of the lesion score and oocyst index, were indicative for E. tenella 
infection. At the end of the treatment, the effi cacy of therapy with sulfachlorpyrazine 
was manifested by lesion score and oocyst index equal to zero. Signifi cant differences 
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in the body weight between the group of healthy, the group of infected and the group of 
infected and treated chickens were in line with the reported changes that occurs due to 
coccidiosis (KETTUNEN et al., 2001; NODEH et al., 2008). Sulfachlorpyrazine treatment 
allowed normalization of weight gains due to improvement of the integrity and function 
of the intestinal mucosa. Mean mortality rate of almost 30% allow us to perform the 
planned experiment with high resemblance of clinical trial. The group of healthy and 
infected animals consumed amount of water that ensure achievement of nearly equal dose 
of sulfachlorpyrazine in both groups. 
According to our results, pharmacokinetics of sulfachlorpyrazine is signifi cantly 
affected by the clinical and biochemical changes during coccidiosis in chicken. The rate 
of the absorption of the drug was signifi cantly decreased in infected animals. Although 
higher water consumption was expected in the infected chickens, severe increase in 
total mucosal thickness, a decrease in villus height, damage of the epithelial cells and 
decreased motility of the gastro-intestinal tract, altogether cause slow and incomplete 
absorption and later achievement of maximum concentrations in the serum during the 
fi rst 24 hours of the treatment. The elimination half-life and MRT were not signifi cantly 
affected by the disease. Similar changes were observed in previous studies with E. tenella 
infected chickens and turkeys (LASHEV, 1998). More interestingly, differences in the 
value of Tmax between healthy and infected chickens disappeared during the course of 
the treatment but signifi cant changes in serum concentrations were observed. Although 
MRT was insignifi cantly longer and accumulation index was insignifi cantly higher, the 
measured Cmax, and calculated Cavg and Cmin were signifi cantly increased in the infected 
animals. Slower absorption and elimination rates resulted in higher accumulation of 
sulfachlorpyrazine in the serum and tissues of the infected group of animals. Almost 
double concentrations and accumulation was found in the intestinal wall of the caeca and 
of the duodenum, and in the liver. Signifi cantly higher concentrations in the intestinal 
content during the course of the treatment could be attributed to the decreased motility 
of the intestines and increased feed passage time. Decrease in pH of the infected area of 
intestines also can contribute to the trapping of the drug molecules (KETTUNEN et al., 
2001; NODEH et al., 2008). Together with impaired integrity of the intestines, the measured 
concentrations in the content of the caeca contribute to higher penetration of the drug in 
the intestinal cells and to the higher absorption. Although E. tenella infection is strongly 
localized in the caeca, clinical, pathological and biochemical changes are generalized 
and liver and kidney function is affected which can have impact on the duration of 
the withdrawal time (GEORGIEVA et al., 2010). Our rough estimations on the basis of 
mean concentrations show that the withdrawal time in infected animals treated with 
sulfachlorpyrazine for three days is longer in comparison to the healthy chickens. 
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In conclusion, our study shows that pathological changes in E. tenella infected 
chickens contribute to slower absorption and elimination rate of sulfachlorpyrazine 
which resulted in higher accumulation of the drug in the body. Altogether these changes 
suggest that the achieved concentrations in the infected tissues such as caeca signifi cantly 
contribute to the effi cacy of the treatment. On the basis of the analyzed data, a longer 
withdrawal time can be expected in infected animals. 
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HARITOVA, A. M., L. D. LASHEV, V. C. KOINARSKI: Raspodjela sulfaklorpirazina 
u pilića invadiranih vrstom Eimeria tenella. Vet. arhiv 83, 211-222, 2013.
SAŽETAK
Kontrola kokcidioze u pilića pretežito se provodi primjenom protukokcidijskih lijekova (kokcidiostatika). 
Natrijev sulfaklorpirazin se još uvijek rabi kao učinkovit kokcidiocidni sastojak za liječenje peradi s kliničkim 
znakovima kokcidioze. Ipak, njegova raspodjela nakon tri dana liječenja nije dovoljno istražena u pilića 
zaraženih vrstom Eimeria tenella. Farmakokinetika natrijeva sulfaklorpirazina u ovom je radu istražena u zdravih 
i pokusno invadiranih pilića parazitom E. tenella. Njegove koncentracije u serumu i tkivima bile su određivane 
metodom HPLC-PDA. Vrijednosti poluvremena apsorpcije (17,24 ± 3,50 h) i vremena za postizanje najvećih 
koncentracija u serumu Tmax (23,41 ± 3,78 h) bile su značajno veće u zaraženih pilića. Procijenjeni akumulacijski 
indeks bio je 1,22 ± 0,13, a značajno veće serumske koncentracije bile su ustanovljene u zaraženih životinja. 
Značajno veće razine sulfaklorpirazina bile su dokazane u dvanaesniku, slijepim crijevima i jetri što govori 
da se može očekivati duže vrijeme izlučivanja u zaraženih pilića nakon trodnevne primjene antikokcidijske 
tvari. Ustanovljene promjene u raspodjeli sulfaklorpirazina mogu se pripisati promjeni integriteta crijeva i 
smanjenom motilitetu želučano-crijevnog sustava kod kliničke kokcidioze. 
Ključne riječi: pilići, kokcidioza, Eimeria tenella, farmakokinetika, sulfaklorpirazin________________________________________________________________________________________
